Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00696111 · ClinicalTrials.gov registry record · NA
Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
A NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00696111 is a NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome that has completed, run by University of Chicago. The registered enrollment target is 18 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00696111, a NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at the metabolic (use of energy) and hormonal features of sleep problems in women with polycystic ovary syndrome (PCOS).
Conditions Studied
Interventions
- DRUG Depot Lupron followed by estrogen plus placebo
Study Locations (1)
Illinois
- University of Chicago Department of Medicine, Section of Endocrinology, Diabetes & Metabolism - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-12 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00696111
The ClinicalTrials.gov registry entry for NCT00696111 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (92% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Depot Lupron followed by estrogen plus placebo is the first listed.
NCT00696111 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00696111 about?
NCT00696111 is a clinical study titled "Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea". The purpose of this study is to look at the metabolic (use of energy) and hormonal features of sleep problems in women with polycystic ovary syndrome (PCOS).
What is the current status of trial NCT00696111?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2007-12. Estimated completion is 2022-06-30.
What conditions does trial NCT00696111 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Polycystic Ovary Syndrome.
What interventions are being tested in trial NCT00696111?
The interventions under investigation include: Depot Lupron followed by estrogen plus placebo (DRUG).
Who is sponsoring clinical trial NCT00696111?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00696111 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.